2019
DOI: 10.5152/eurjrheum.2019.18182
|View full text |Cite
|
Sign up to set email alerts
|

Survey on transportation and storage of biological therapies by patients

Abstract: Objective To assess key aspects of transportation and storage of biological therapies (BTs) on the part of the patients, from the time they collect them from the pharmacy up until the moment of administration. Methods This was a cross-sectional study in the form of a survey completed by outpatients older than 18 years who were administered BTs. The survey was carried out by the authors between August 2016 and January 2017. Results A total of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Biologics and biosimilars must be transported and stored at highly regulated temperatures [25]. Notably, most HCPs (81.3%) recognised that storing BMs outside their recommended storage conditions may introduce or alter immunogenicity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Biologics and biosimilars must be transported and stored at highly regulated temperatures [25]. Notably, most HCPs (81.3%) recognised that storing BMs outside their recommended storage conditions may introduce or alter immunogenicity.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, most HCPs (81.3%) recognised that storing BMs outside their recommended storage conditions may introduce or alter immunogenicity. Temperature fluctuations may increase the formation of protein aggregates and therefore affect the product quality [25].…”
Section: Discussionmentioning
confidence: 99%